Open access
Open access
Powered by Google Translator Translator

Randomized Trials

Cluster RCT: In adults with out-of-hospital cardiac arrest, placement of a supraglottic airway device resulted in similar rates of sustained return of spontaneous circulations compared to endotracheal intubation.

2 Mar, 2022 | 09:07h | UTC

Effect of Placement of a Supraglottic Airway Device vs Endotracheal Intubation on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest in Taipei, Taiwan: A Cluster Randomized Clinical Trial – JAMA Network Open

Commentary: Cardiac Arrest Patients Don’t Necessarily Do Better With Intubation— Debate on prehospital advanced airway management continues – MedPage Today (free registration required)

 

Commentary on Twitter

 


RCT: Arthroscopic hip surgery compared with personalized hip therapy in people over 16 years old with femoroacetabular impingement syndrome.

2 Mar, 2022 | 09:04h | UTC

Abstract: Arthroscopic hip surgery compared with personalised hip therapy in people over 16 years old with femoroacetabular impingement syndrome: UK FASHIoN RCT – Health Technology Assessment

Download Full Report

Related: Randomized Trial: Arthroscopic Hip Surgery vs. Physiotherapy and Activity Modification for the Treatment of Femoroacetabular Impingement

 


RCT: Referral for early, supported exercise after breast cancer surgery improves shoulder function and health-related quality of life.

1 Mar, 2022 | 08:50h | UTC

Abstract: Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT – Health Technology Assessment

Full Report: Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT – Health Technology Assessment

Related: RCT: Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer–Related Lymphedema.

 


RCT: Sublingual dexmedetomidine reduces mild to moderate acute agitation in patients with bipolar disorder.

23 Feb, 2022 | 10:18h | UTC

Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Sublingual Dexmedetomidine as a Potential New Treatment for Agitation – JAMA (free for a limited period)

 

Commentary on Twitter

 


RCT: Full endoscopic discectomy non-inferior to open discectomy in patients with sciatica.

22 Feb, 2022 | 10:11h | UTC

Full endoscopic versus open discectomy for sciatica: randomised controlled non-inferiority trial – The BMJ

Commentary: Full-endoscopic transforaminal discectomy is “an effective alternative” to open microdiscectomy in treating sciatica – Spinal News International

 


RCT: Time to functional recovery after laser tonsillotomy performed under local anesthesia vs. conventional tonsillectomy with general anesthesia among adults.

22 Feb, 2022 | 08:22h | UTC

Time to Functional Recovery After Laser Tonsillotomy Performed Under Local Anesthesia vs Conventional Tonsillectomy With General Anesthesia Among Adults: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 


RCT: Sub dissociative dose of ketamine with haloperidol vs. fentanyl on pain reduction in patients with acute pain in the emergency department.

21 Feb, 2022 | 08:37h | UTC

Sub dissociative dose of ketamine with haloperidol versus fentanyl on pain reduction in patients with acute pain in the emergency department; a randomized clinical trial – The American Journal of Emergency Medicine (link to abstract – $ for full-text)

 


RCT: Low-dose aspirin did not significantly reduce the risk of preterm birth in women with a previous spontaneous preterm birth (RR 0.83; 95% CI 0.58 to 1.20; p = 0.32).

21 Feb, 2022 | 08:33h | UTC

Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial – PLOS Medicine

 


RCT: Single-dose metronidazole vs. treatment for 7 days for treating Trichomonas vaginalis in women.

21 Feb, 2022 | 08:23h | UTC

A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women – Sexually Transmitted Diseases (link to abstract – $ for full-text)

 


RCT: Two vs. three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced esophageal squamous cell carcinoma.

21 Feb, 2022 | 08:25h | UTC

Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma – British Journal of Cancer (link to abstract – read for free here)

 

Commentary on Twitter

 


RCT: Perianal application of glyceryl trinitrate ointment vs. tocopherol acetate ointment for treating chronic anal fissure.

21 Feb, 2022 | 08:26h | UTC

Perianal Application of Glyceryl Trinitrate Ointment Versus Tocopherol Acetate Ointment in the Treatment of Chronic Anal Fissure: A Randomized Clinical Trial – Diseases of the Colon & Rectum (link to abstract – $ for full-text)

 


RCT: Oral Nirmatrelvir for high-risk adults with Covid-19 reduces the risk of hospitalization by 89%.

17 Feb, 2022 | 10:14h | UTC

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal of Medicine

Audio Interview: A New Antiviral against Covid-19 – new England Journal of Medicine

Related:

[Press release – not published yet] Pfizer’s Covid pill remains 89% effective for reducing the risk of hospitalization or death in final analysis.

[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.

Statement on potential drug-drug interactions between Ritonavir-boosted Nirmatrelvir (Paxlovid) and concomitant medications; antiarrhythmics, oral anticoagulants, immunosuppressants, anticonvulsants, antineoplastics, and neuropsychiatric drugs are among the drugs of concern.

 

Commentary on Twitter

 


RCT: L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy.

17 Feb, 2022 | 08:35h | UTC

L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial – Hepatology (link to abstract – $ for full-text)

 


Efficacy, durability, and safety of intravitreal Faricimab up to every 16 weeks for neovascular age-related macular degeneration: two randomized, double-masked, phase 3, non-inferiority trials.

15 Feb, 2022 | 08:29h | UTC

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials – The Lancet (link to abstract – $ for full-text)

Commentary: Trials Show Promise for Intravitreal Faricimab in Retinal Disease – HealthDay

 


RCT: Effects of a 6-month, low-carbohydrate diet on glycemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes.

13 Feb, 2022 | 22:35h | UTC

Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: An open-label randomized controlled trial – Diabetes, Obesity and Metabolism

 


RCT: Primary Norfloxacin prophylaxis prevents bacterial infections in patients with acute-on-chronic liver failure.

13 Feb, 2022 | 22:37h | UTC

Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial – The American Journal of Gastroenterology (link to abstract – $ for full-text)

 


RCT: In patients with cardiogenic shock receiving VA-ECMO, moderate hypothermia did not significantly reduce 30-day mortality. 42% of patients in the moderate hypothermia group died vs. 51% in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.45 to 1.13], P = .15).

13 Feb, 2022 | 22:11h | UTC

Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

Commentary: Hypothermia vs. Normothermia for Cardiogenic Shock Patients on VA-ECMO – American College of Cardiology

 

Commentary on Twitter

 


RCT: In patients with contaminated ventral hernias undergoing repair, synthetic Mesh reduced hernia recurrence risk compared with biologic Mesh.

13 Feb, 2022 | 22:05h | UTC

Biologic vs Synthetic Mesh for Single-stage Repair of Contaminated Ventral Hernias: A Randomized Clinical Trial – JAMA Surgery (link to abstract – $ for full-text)

 

Commentary on Twitter

 


RCT: Subcutaneous Tirzepatide added to titrated Insulin Glargine improves glycemic control in patients with Type 2 Diabetes.

10 Feb, 2022 | 10:00h | UTC

Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Tirzepatide for Patients With Type 2 Diabetes – JAMA

Commentary: SURPASS-5 Data: Tirzepatide Plus Insulin Glargine Improve Glycemic Control in T2D – AJMC

Related:

RCT: In patients with Type 2 Diabetes, Tirzepatide is associated with reduced weight, improved glycemic control, and lower risk of hypoglycemia compared to insulin glargine.

RCT: Once-weekly tirzepatide vs. once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes.

RCT: Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2.

RCT: Tirzepatide yielded greater glycated hemoglobin and body weight reductions compared to Semaglutide 1 mg.

 


RCT: Home phototherapy of term neonates improves parental bonding and stress.

10 Feb, 2022 | 08:25h | UTC

Home phototherapy of term neonates improves parental bonding and stress: Findings from a randomised controlled trial – Acta Paediatrica

 

Commentary on Twitter

 


Randomized trial suggests it is safe to withhold antimicrobial prophylaxis in patients undergoing transurethral resection of the prostate without preoperative pyuria or preoperative indwelling catheter.

9 Feb, 2022 | 08:41h | UTC

Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial – The Journal of Urology (link to abstract – $ for full-text)

 


RCT: Ketamine is a short-term effective treatment for some suicidal patients in hospital.

4 Feb, 2022 | 10:05h | UTC

News Release: Ketamine is a short-term effective treatment for some suicidal patients in hospital – BMJ

Original Article: Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial – The BMJ

Editorial: Ketamine for suicidal ideation – The BMJ

Related:

RCT: Ketamine induced remission in 46% of patients but was NOT non-inferior to electroconvulsive therapy for the treatment of hospitalized patients with unipolar depression.

Systematic Review: Ketamine for the treatment of mental health and substance use disorders.

Phase 2 RCT: Adjunctive ketamine with relapse prevention–based psychological therapy shows promise for the treatment of alcohol use disorder.

RCT: Effects of ketamine vs. midazolam on neurocognition at 24 hours in depressed patients with suicidal ideation.

Randomized trial: Repeated Ketamine administration for chronic posttraumatic stress disorder

Ketamine and Depression: A Narrative Review

 


RCT: Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer–Related Lymphedema.

4 Feb, 2022 | 08:35h | UTC

Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer–Related Lymphedema: A Randomized Controlled Trial – Journal of Clinical Oncology

 


Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer.

4 Feb, 2022 | 08:38h | UTC

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer – Journal of Clinical Oncology

Original Study: Randomized Trial: Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

 


Cluster randomized controlled trial: An innovative telemedical network to improve infectious disease management in critically ill patients and outpatients.

3 Feb, 2022 | 08:53h | UTC

An innovative telemedical network to improve infectious disease management in critically ill patients and outpatients: a stepped-wedge, cluster randomized controlled trial (TELnet@NRW) – Journal of Medical Internet Research

Related:

The “Choosing Wisely” initiative in infectious diseases – German Society of Infectious Diseases (link to abstract – $ for full-text)

Infectious Diseases Society of America: Five Things Physicians and Patients Should Question

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.